|
MechanismBacterial DNA gyrase inhibitors [+2] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date17 Dec 2014 |
100 Clinical Results associated with Fonseca Biosciences, LLC
0 Patents (Medical) associated with Fonseca Biosciences, LLC
100 Deals associated with Fonseca Biosciences, LLC
100 Translational Medicine associated with Fonseca Biosciences, LLC